Media Summary: The FDA recently approved Kalydeco, the first drug to address the underlying cause of CFTR modulators have fundamentally changed the Jennifer Taylor-Cousar, M.D., M.S.C.S., ATSF, co-director and
Cf Foundation Will Corcoran - Detailed Analysis & Overview
The FDA recently approved Kalydeco, the first drug to address the underlying cause of CFTR modulators have fundamentally changed the Jennifer Taylor-Cousar, M.D., M.S.C.S., ATSF, co-director and In the first session of our Tomorrow's Leaders College Program, we heard from three adults living with Watch the webcast to hear two experts discuss what schools Growing up, Caleb Remington, an adult with
Need to appeal a Medicare claim? Whether you are newly diagnosed with Amazing people, who are at the heart of what we all do to understand, treat and cure
